Central Trust CO Dexcom Inc Transaction History

Central Trust CO

$4.19 Billion
Q3 2024

A detailed history of Central Trust CO transactions in Dexcom Inc stock. As of the latest transaction made, Central Trust CO holds 4,269 shares of DXCM stock, worth $341,690. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,269

Previous 4,275 0.14%

Holding current value

$341,690

Previous $484,000 40.91%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$64.0 - $116.06 $384 - $696	-6 Reduced 0.14%	4,269 $286,000
Q2 2024 Aug 05, 2024	SELL	$110.31 - $140.45 $53,500 - $68,118	-485 Reduced 10.19%	4,275 $484,000
Q1 2024 Apr 24, 2024	SELL	$114.22 - $140.1 $17,704 - $21,715	-155 Reduced 3.15%	4,760 $660,000
Q4 2023 Jan 24, 2024	BUY	$75.49 - $124.16 $3,397 - $5,587	45 Added 0.92%	4,915 $609,000
Q3 2023 Oct 26, 2023	BUY	$86.06 - $137.93 $8,606 - $13,793	100 Added 2.1%	4,870 $454,000
Q2 2023 Jul 26, 2023	SELL	$112.47 - $130.98 $21,594 - $25,148	-192 Reduced 3.87%	4,770 $612,000
Q1 2023 Apr 19, 2023	SELL	$104.0 - $122.92 $3,328 - $3,933	-32 Reduced 0.64%	4,962 $576,000
Q4 2022 Jan 26, 2023	SELL	$84.98 - $122.67 $25,324 - $36,555	-298 Reduced 5.63%	4,994 $0
Q3 2022 Nov 17, 2022	SELL	$76.35 - $94.18 $18,018 - $22,226	-236 Reduced 4.27%	5,292 $426,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $299,223 - $584,848	4,401 Added 390.51%	5,528 $412,000
Q1 2022 May 03, 2022	BUY	$94.08 - $130.2 $1,975 - $2,734	21 Added 1.9%	1,127 $144,000
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $779 - $976	6 Added 0.55%	1,106 $148,000
Q4 2017 Jan 23, 2018	BUY	$11.12 - $15.38 $1,112 - $1,538	100 Added 10.0%	1,100 $0
Q3 2017 Oct 17, 2017	BUY	$11.36 - $18.98 $11,360 - $18,980	1,000	1,000 $0

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account